NASDAQ
4.11USD
+0.04 (+0.98%)
We have scored 10 news catalysts on Whitehawk Therapeutics Inc (WHWK) over the past 12 months. The biggest single-day move next to one of them came May 21, 2026, when WHWK closed +1.9%: “Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload”. Coverage across the window leans positive (average ticker sentiment +0.63). Most of the impact sits in sector healthcare and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
234.3M
P/E
—
EPS
—
Beta
0.81
52W range
1.8-5.495
Day range
4.08–4.27
Open
4.12
Prev close
4.07
Volume
283.5K
Avg volume
460.2K
Dividend
0.00
IPO
2017-08-01
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Whitehawk Therapeutics Inc — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for WHWK: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
